Department of Hematology, University of Crete School of Medicine, Heraklion, Greece.
Haematologica. 2013 Aug;98(8):1206-15. doi: 10.3324/haematol.2012.064642. Epub 2013 Feb 12.
Excessive pro-inflammatory cytokine production in the bone marrow has been associated with the pathogenesis of myelodysplastic syndromes. We herein investigated the involvement of toll-like receptors and their endogenous ligands in the induction/maintenance of the inflammatory process in the marrow of patients with myelodysplastic syndromes. We evaluated the expression of toll-like receptors in marrow monocytes of patients (n=27) and healthy controls (n=25) by flow-cytometry and also assessed the activation of the respective signaling using a real-time polymerase chain reaction-based array. We measured the high mobility group box-1 protein, a toll-like receptor-4 ligand, in marrow plasma and long-term bone marrow culture supernatants by an enzyme-linked immunosorbent assay and we performed cross-over experiments using marrow plasma from patients and controls in the presence/absence of a toll-like receptor-4 inhibitor to evaluate the pro-inflammatory cytokine production by chemiluminescence. We assessed the apoptotic cell clearance capacity of patients' macrophages using a fluorescence microscopy-based assay. We found over-expression of toll-like receptor-4 in patients' marrow monocytes compared to that in controls; this over-expression was associated with up-modulation of 53 genes related to the respective signaling. Incubation of patients' monocytes with autologous, but not with normal, marrow plasma resulted in over-production of pro-inflammatory cytokines, an effect that was abrogated by the toll-like receptor-4 inhibitor suggesting that the pro-inflammatory cytokine production in myelodysplastic syndromes is largely mediated through toll-like receptor-4. The levels of high mobility group box-1 protein were increased in patients' marrow plasma and culture supernatants compared to the levels in controls. Patients' macrophages displayed an impaired capacity to engulf apoptotic cells and this defect was associated with excessive release of high mobility group box-1 protein by dying cells. A primary apoptotic cell clearance defect of marrow macrophages in myelodysplastic syndromes may contribute to the induction/maintenance of the inflammatory process through aberrant release of molecules inducing toll-like receptor-4 such as high mobility group box-1 protein.
骨髓中过度的促炎细胞因子产生与骨髓增生异常综合征的发病机制有关。在此,我们研究了 Toll 样受体及其内源性配体在诱导/维持骨髓增生异常综合征患者炎症过程中的作用。我们通过流式细胞术评估了骨髓单核细胞中 Toll 样受体的表达,研究对象为骨髓增生异常综合征患者(n=27)和健康对照者(n=25),并通过实时聚合酶链反应阵列评估了相应信号的激活情况。我们通过酶联免疫吸附试验测量了骨髓血浆和长期骨髓培养上清液中的高迁移率族蛋白 1 (Toll 样受体 4 的配体),并在存在/不存在 Toll 样受体 4 抑制剂的情况下,采用患者和对照者的骨髓血浆进行交叉实验,以评估化学发光法下促炎细胞因子的产生情况。我们采用基于荧光显微镜的检测方法评估了患者巨噬细胞的凋亡细胞清除能力。与对照组相比,患者骨髓单核细胞中 Toll 样受体 4 的表达过度;这种过表达与 53 个与相应信号相关的基因的上调有关。与自体骨髓血浆孵育而不是与正常骨髓血浆孵育患者的单核细胞会导致促炎细胞因子过度产生,这种作用可以被 Toll 样受体 4 抑制剂所阻断,这表明骨髓增生异常综合征中促炎细胞因子的产生在很大程度上是通过 Toll 样受体 4 介导的。与对照组相比,患者骨髓血浆和培养上清液中的高迁移率族蛋白 1 水平升高。患者的巨噬细胞表现出吞噬凋亡细胞的能力受损,这种缺陷与死亡细胞过度释放高迁移率族蛋白 1 有关。骨髓巨噬细胞中初始的凋亡细胞清除缺陷可能通过异常释放诱导 Toll 样受体 4 的分子(如高迁移率族蛋白 1 ),从而导致炎症过程的诱导/维持。